PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Science Arts, Inc.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

Science Arts, Inc. owes ¥0.34 for every ¥1 it owns. Science Arts, Inc. returned to profit in the year to Aug 2025, after a loss the year before.

Compared with Technology companies in Japan · latest annual results Aug 2025.

P/E ratio

41.7

Investors pay ¥41.7 for every ¥1 of Science Arts, Inc.'s yearly profit, higher than 86% of Technology companies in Japan.

P/B ratio

6.79

The share price is 6.79 times Science Arts, Inc.'s book value per share, higher than 90% of Technology companies in Japan.

Market cap

¥10.5 B

The total market value of all of Science Arts, Inc.'s shares at today's price (share price × number of shares), smaller than 57% of Technology companies in Japan. PosiCap size class: Micro Cap.

Net worth (book value)

¥1.5 B

What Science Arts, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 May 2026).

Book value per share

¥189.92

Net worth divided by the number of shares. The share price of ¥1,290 is 6.8 times this, which is the P/B above.

Return on equity (ROE)

16.6%

Science Arts, Inc. earned 16.6% on its shareholders' money over the last year, higher than 72% of Technology companies in Japan.

Owes vs Owns

0.34×

Science Arts, Inc. owes ¥0.34 for every ¥1 it owns (low), lower than 56% of Technology companies in Japan.

Dividend yield

0.16%

Science Arts, Inc. pays 0.16% of its share price as dividends a year, lower than almost all dividend-paying Technology companies in Japan.

Revenue growth

+40%

Revenue rose 40% in the year to Aug 2025, and grew 36% a year on average over 3 years.

Profit growth

Back to profit

Science Arts, Inc. returned to profit in the year to Aug 2025, after a loss the year before.

Profit margin

6.8%

Science Arts, Inc. keeps ¥7 of every ¥100 of revenue as net profit.

Cash quality

2.6×

Cash from Science Arts, Inc.'s business was 2.6× its reported profit in the year to Aug 2025 — its profit turned into cash.

Interest cover

64.3×

Science Arts, Inc.'s operating profit covered its interest costs 64.3 times in the year to Aug 2025.

Cash vs debt

Net cash

Science Arts, Inc. held ¥1.5 B more cash than debt (net cash) at Aug 2025.

Questions

What is Science Arts, Inc.'s P/E ratio?

Investors pay ¥41.7 for every ¥1 of Science Arts, Inc.'s yearly profit, higher than 86% of Technology companies in Japan.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Science Arts, Inc.: ¥10.5 B ÷ ¥1.5 B (31 May 2026) = 6.8.

What is Science Arts, Inc.'s return on equity?

Science Arts, Inc. earned 16.6% on its shareholders' money over the last year, higher than 72% of Technology companies in Japan.

How much does Science Arts, Inc. owe compared with what it owns?

Science Arts, Inc. owes ¥0.34 for every ¥1 it owns (low), lower than 56% of Technology companies in Japan.

Does Science Arts, Inc. pay a dividend?

Yes. Science Arts, Inc. pays 0.16% of its share price as dividends a year, lower than almost all dividend-paying Technology companies in Japan.

Is Science Arts, Inc.'s revenue growing?

Revenue rose 40% in the year to Aug 2025, and grew 36% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.